Abemaciclib

Abemaciclib


Abemaciclib (LY2835219) is an orally bioavailable, selective CDK4/6 inhibitor (IC50: 2 nM, 10 nM). It blocks retinoblastoma protein phosphorylation, inducing G1 phase arrest. Abemaciclib exhibits antitumor activity alone or in combination with other therapies in xenograft models. Reagent grade, for research use only.

Molecular structure of the compound BP-43621
    • Unit
    • Price
    • Qty
    • 500 MG
    • $120.00
    • 1 G
    • $210.00
    • 5 G
    • $480.00

Usually ships within 24 hours.


Would you like to inquire about custom quantity?
Inquire